Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ambroxol-theophylline-7-acetate
1. Ambroxol Acefyllinate
2. Ambromucil
3. Broncomnes
4. Surfolase
5. 96989-76-3
6. Ambroxol Theophyllinacetate
7. 179118-73-1
8. Ambroxol-theophylline-7-acetate
9. Ambroxol Theophyllinate
10. 0hm1e174tn
11. 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetic Acid
12. Cyclohexanol, 4-(((2-amino-3,5-dibromophenyl)methyl)amino)-, Trans-, Mono(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7h-purine-7-acetate) (salt)
13. Unii-0hm1e174tn
14. Schembl1650322
15. Chembl4297663
16. Dtxsid60914235
17. Glxc-26022
18. Bcp28655
19. Ambroxol Acefyllinate [mart.]
20. Akos015899892
21. Ambroxol Acefyllinate [who-dd]
22. Db13141
23. Ambroxol Theophyllinate [who-dd]
24. Ambromucil Pound>>ambroxol-theophylline-7-acetate
25. Q19607226
26. (1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7h-purin-7-yl)acetic Acid--4-{[(2-amino-3,5-dibromophenyl)methyl]amino}cyclohexan-1-ol (1/1)
27. 7h-purine-7-acetic Acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-, Compd. With Trans-4-(((2-amino-3,5-dibromophenyl)methyl)amino)cyclohexanol (1:1)
| Molecular Weight | 616.3 g/mol |
|---|---|
| Molecular Formula | C22H28Br2N6O5 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 5 |
| Exact Mass | 616.04674 g/mol |
| Monoisotopic Mass | 614.04879 g/mol |
| Topological Polar Surface Area | 154 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 645 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
ABOUT THIS PAGE
A Acebrophylline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acebrophylline, including repackagers and relabelers. The FDA regulates Acebrophylline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acebrophylline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Acebrophylline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Acebrophylline supplier is an individual or a company that provides Acebrophylline active pharmaceutical ingredient (API) or Acebrophylline finished formulations upon request. The Acebrophylline suppliers may include Acebrophylline API manufacturers, exporters, distributors and traders.
click here to find a list of Acebrophylline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Acebrophylline Drug Master File in Korea (Acebrophylline KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Acebrophylline. The MFDS reviews the Acebrophylline KDMF as part of the drug registration process and uses the information provided in the Acebrophylline KDMF to evaluate the safety and efficacy of the drug.
After submitting a Acebrophylline KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Acebrophylline API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Acebrophylline suppliers with KDMF on PharmaCompass.
A Acebrophylline written confirmation (Acebrophylline WC) is an official document issued by a regulatory agency to a Acebrophylline manufacturer, verifying that the manufacturing facility of a Acebrophylline active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Acebrophylline APIs or Acebrophylline finished pharmaceutical products to another nation, regulatory agencies frequently require a Acebrophylline WC (written confirmation) as part of the regulatory process.
click here to find a list of Acebrophylline suppliers with Written Confirmation (WC) on PharmaCompass.
Acebrophylline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Acebrophylline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Acebrophylline GMP manufacturer or Acebrophylline GMP API supplier for your needs.
A Acebrophylline CoA (Certificate of Analysis) is a formal document that attests to Acebrophylline's compliance with Acebrophylline specifications and serves as a tool for batch-level quality control.
Acebrophylline CoA mostly includes findings from lab analyses of a specific batch. For each Acebrophylline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Acebrophylline may be tested according to a variety of international standards, such as European Pharmacopoeia (Acebrophylline EP), Acebrophylline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Acebrophylline USP).
LOOKING FOR A SUPPLIER?
